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Abstract
Dendritic cells (DCs) are the most potent antigen-presenting cells (APCs) in priming naive T cells.
Using an in vitro priming system, we show that DCs incubated with Ixodes ricinus tick saliva initiate
the Th2 differentiation of CD4
1T cells. As determined with reverse transcription–PCR, the expression
of IL-4 mRNA by these cells is higher than IFN-g mRNA. Early endogenous production of IL-4 is
thought to be important during the in vitro interaction of saliva-pulsed DCs with CD41T cells. Its
neutralization with specific mAbs inhibits the development of IL-4-secreting Th2 cells. Moreover,
differentiated Th2 cells proliferate only when saliva-pulsed DCs and IL-1b are added together early in
the primary culture. As demonstrated by FACS analysis, the treatment in vitro of saliva-pulsed DCs by
IL-1b enhanced the expression of B7 and mainly CD40 co-stimulatory molecules, which provide
sufficient signals to stimulate sensitized CD41T cell proliferation. On the other hand, DCs treated with
tick saliva only up-regulated mostly B7-2 co-stimulator expression and this was associated with
differentiation of naive CD41T cells into Th2 type of cells. The in vitro priming system is suitable to
investigate the major elements implicated in the anti-tick immune response such as naive CD41T
cells, whole DCs population and tick saliva, and it can provide the possibility to delimit further the
saliva molecules, the DC subsets and the type of host cells involved in the Th2 polarization.
Corresponding in vivo experiments involving subcutaneous injection of tick saliva-pulsed DCs into
BALB/c mice also elicited a Th2 immune response. Ex vivo cultures of draining lymph node T cells
stimulated with tick saliva produced higher IL-4 : IFN-g ratios compared with controls, confirming the
relevance obtained in the in vitro priming model. These experiments demonstrate the importance of
tick saliva in priming DCs to initiate a Th2-biased immune response in vitro and in vivo.
Introduction
Cytokines produced by CD4+T cells polarize the immune re-
sponse in vivo or in vitro in response to antigen challenge.
Th1 cells are characterized by the predominance of IFN-c
production while Th2 cells produce predominantly IL-4 (1).
This dichotomy in T helper activity is in part reported to be
associated with susceptibility or resistance to pathogens. In
experimental murine cutaneous leishmaniasis, selective acti-
vation of Th1 cells is associated with resolution of the dis-
ease whereas selective activation of Th2 cells with disease
progression (2). Vectors such as tick or sand fly inject patho-
gens into skin along with saliva. Salivary gland lysate of the
old world sand fly Phlebotomus papatasi exacerbates lesion
size and enhances Leishmania major burden in disease-
resistant CBA mice. This observation is correlated with inhi-
bition of the production of Th1, and enhancement of Th2
cytokines (3). In BALB/c mice infested by Ixodes ricinus
ticks infected with Borrelia burgdorferi, anti-borrelial IgG2a
production is diminished in comparison with mice infected
with a syringe (4). These examples reveal that ectoparasite
saliva promotes a Th2-type immune response. Pathogen-free
I. ricinus instars elicit also a Th2 immune response in BALB/c
(H-2d) as well as other strains of mice such as DBA (H-2d),
C57BL/6 (H-2b), C3H (H-2k), CBA (H-2k), SJL (H-2s) and
FVB (H-2q) (5, 6). Many factors have been reported to be
implicated independently or together in the polarization of
the immune response in vivo (7). In mice infested with
I. ricinus, neither the host genetic background nor the infes-
tation intensity modified the orientation of the immune re-
sponse (6). The molecular nature of tick saliva and the
environment of the infested skin may finally determine the
Published in International Immunology 19, issue 4, 535-543, 2007
which should be used for any reference to this work
1
differentiation of naive CD4+T cells into Th2 cells. The activa-
tion of CD4+T cells occurs mostly in secondary lymphoid
organs and requires antigen-presenting cells (APCs). Den-
dritic cells (DCs) are widely distributed in the body and are
the most important cells implicated in this activation (8). The
original microenvironment of DCs including cytokines and
antigens may influence their priming capacity to differentiate
naive CD4+T cells along either a Th1 or Th2 pathway (9).
In our work an in vitro priming system has been set up. It
reproduces the in vivo leukocyte reaction and brings out the
importance of tick saliva for the polarization of the immune
response. DCs pulsed with tick saliva induce the Th2 differ-
entiation of naive CD4+T cells in vitro, and when injected
subcutaneously into BALB/c mice also in vivo. The treatment
of in vitro cultures with neutralizing anti-IL-4 mAbs revealed
the necessity of the early production of endogenous IL-4 to
direct the immune response toward Th2. Moreover, the early
addition of exogenous IL-1b into the leukocyte reaction was
found to be necessary for the proliferation, but not for the
differentiation of Th2 cells in vitro. IL-1b treatment of tick sa-
liva-pulsed DCs enhanced the expression of the main ac-
cessory molecules B7-2 and CD40, which render them able
to drive responder Th2 cells proliferation. In the case of tick
infestation, IL-1b appears to be necessary for the activation




Male rabbits (New Zealand) weighing an average 3 kg and
BALB/c female mice 8- to 12-weeks old are purchased from
Elevage des Dombes (Romans, France) and IFFA-CREDO
(Arbresle, France), respectively. Ixodes ricinus adult female
ticks were reared in our laboratory as previously described
(10).
Tick saliva preparation
To collect saliva, adult I. ricinus ticks were allowed to feed
for 5 days and 12 h on rabbit’s ears. Partially engorged fe-
male ticks were removed and fixed by their dorsum on
a sticky paper. To enhance the salivation, 5 ll of dopamine
solution 0.2% (w/v) (Fluka, Buchs, Switzerland) in 50 mM
PBS, pH 7.4, were injected into the haemocoele of the tick
using a 0.3 3 13-mm needle (Becton Dickinson, Switzer-
land) (11). A finely drawn capillary tube of 20 ll of counte-
nance was fitted over the mouthparts of each tick which
was allowed to salivate for 20–40 min. The volume provided
by each tick was 3 ll in average. Saliva from 100 partially
fed ticks was pooled and stored at 20C until use. Protein
concentration of saliva was determined using BCA Protein
Assay Kit (Pierce, Socochim, Switzerland).
DCs separation
A cellular suspension was obtained by teasing BALB/c mice
spleens with a large striated forceps. The RBCs were re-
moved by incubation in ACK hypotonic lysis buffer (0.15 M
NH4Cl, 1 mM KHCO3, 0.1 mM Na2EDTA) during 5–10 s.
Cells/spleen (5 3 107) were washed and suspended in
HBSS + 20% FCS. They were used to discard firstly macro-
phages that allowed to adhere to a Petri dish during 1 h at
37C, and non-adherent cells were then re-suspended in the
isolation buffer containing PBS 50 mM, pH 7.4, supple-
mented with 5% decomplemented FCS and 5% decomple-
mented normal rat serum and 1 mM EDTA. They were ready
for DCs separation by a negative selection system, using
the StemSep biotinylated antibody cocktail (Biocoba,
Switzerland) in combination with StemSep magnetic colloid.
The antibody cocktail contains biotinylated mAbs to the follow-
ing mouse cell-surface antigens: CD2, CD3, CD19, TER 119,
Ly-6G (gr-1) and neutrophils (7–4). These antibodies target
and retain into the column, respectively: thymocytes, pre-B,
B, NK myeloid and erythrocytes; T cells and NKT cells; B cells
and follicular DCs; proerythroblast to mature erythrocytes;
myeloid cells and neutrophils. Consequently, an enriched
fraction of DCs flow through the column. To improve DCs
enrichment, the harvested cells were subject of a second
round of negative selection. Finally after discarding macro-
phages, the StemSep system eliminate unwanted cells to
obtain a highly (>90) enriched DCs which are defined as
CD11c+, I-A+, F4/80low. DCs were finally washed and sus-
pended in RPMI-1640 (GIBCO, Basel, Switzerland), supple-
mented with 10% FCS (v/v), 2 mM L-glutamine, 1 mM
sodium pyruvate, 1 mM non-essential amino acids (Sigma,
Switzerland), 0.05 mM mercaptoethanol, 100 U ml1 penicillin/
streptomycin (GIBCO) and 25 lg ml1 fungizone (GIBCO).
CD4+T cells separation
RBCs-depleted spleen cell suspension prepared from BALB/c
mice was washed twice in HBSS and suspended in the iso-
lation buffer without EDTA. CD4+T cells were then separated
using the StemSep biotinylated antibody cocktail (StemCell,
Basel, Switzerland) for CD4+T cells in combination with
StemSep magnetic colloid, according to the manufacturer’s
instructions. Recovered CD4+T cells (>90% purity) were
washed and suspended in complete RPMI-1640.
CD4+T cell priming in vitro
Cell cultures were set up in 24-well plates (Falcon, Becton
Dickinson, Switzerland). Purified splenic DCs per well (5 3
105) were pulsed in vitro with 15 lg of I. ricinus tick saliva
(which has a concentration of 1 mg ml1) in 500 ll of com-
plete RPMI-1640 during 24 h. Controls received RPMI-1640
alone. Thereafter, 5 3 106 purified CD4+T cells per well were
added in 500 ll of complete RPMI-1640. In some experi-
ments, complete RPMI-1640 medium was supplemented at
the beginning of the culture with neutralizing anti-IL-4 mAbs
(Becton Dickinson) at the concentration of 50 lg ml1. Cul-
tures were maintained during 7 days at 37C and 5% CO2.
Secondary stimulation of primed CD4+T cells in vitro
Cultures were set up in 96-well plates (Falcon, Becton
Dickinson). Purified splenic DCs per well (2 3 104) were
pulsed with 4 ll of tick saliva overnight in vitro in 100 ll of
complete RPMI-1640. Controls were maintained in RPMI me-
dium alone. DCs were then cultivated with 2 3 105 of homol-
ogous CD4+T cells primed in vitro with saliva-pulsed DCs
supplemented or not with 2 ng per well IL-1b (respectively,
2
ps+IL-1b CD4
+T cells and ps CD4
+T cells). As controls, 2 3
104 purified splenic DCs per well pulsed or not with tick sa-
liva were cultured with CD4+T cells primed in vitro with DCs
in the presence of 2 ng IL-1b per well only (pIL-1b CD4
+T
cells). Cultures were maintained in 200 ll total volume of
complete RPMI-1640 during 96 h at 37C and saturated at-
mosphere and 5% CO2. They were pulsed with 1 lCi per
well of methyl [3H]thymidine ([3H]TdR) (specific activity 25
Ci mmol1) (Amersham, Bucks, UK) 24 h before harvesting
the cells. [3H]TdR incorporation was determined by liquid
scintillation counting.
Competitive PCR analysis of cytokine messenger RNA
production
RNA extraction. At the seventh day of primary culture, total
RNA was extracted from collected 5 3 105 CD4+T cells stimu-
lated in vitro with tick saliva-pulsed DCs or DCs alone either
in presence or absence of anti-IL-4. The prescript isolation kit
(Gentra Systems, Minneapolis, MN, USA) was used accord-
ing to manufacturer’s instructions. Briefly following CD4+T cell
lysis, a protein-DNA precipitation solution was added to the
cell lysate. After centrifugation, the supernatant containing
the RNA was removed from the precipitated protein-DNA pel-
let. Total RNA was then precipitated with cold pure isopropa-
nol. The pellet was washed in 70% ethanol, air dried,
suspended in 20 ll of water treated with diethyl pyrocarbon-
ate (DEPC) 1% (Sigma, Switzerland) and stored at 80C un-
til use. One microlitre containing 0.1–0.5 lg of total RNA was
used as template for the reverse transcriptase reaction.
cDNA synthesis. Total RNA was heated to 57C for 10 min,
cooled on ice for 5 min and used as template for the cDNA
synthesis. One microgram of total RNA contained in 5 ll of
DEPC-treated H2O was added to the master mix (kit Omni-
script Qiagen) including 2 ll of reverse transcription buffer
(100 mM Tris, 500 mM KCl, pH 8.3), 2 ll of mixed dNTP, 2 ll
of oligo (dT)15, 1 ll of omniscript reverse transcriptase and
8 ll of sterile H2O. The reaction mixture was incubated for
60 min at 37C, heated to 93C for 5 min and chilled on ice
for 5 min. The cDNA contained in 20 ll total volume was
stored at 20C until use.
Competitive PCR. The first-strand cDNA synthesis kit (Hot-
StarTaq, Qiagen) was used in this competitive PCR. The
semi-quantitative competitive PCR was carried out using
a competitor construct (pPQRS) containing sequences for
multiple cytokines including IL-4 and IFN-c. Primers for IL-4
were 5#-CATCGGCATTTTGAACGAGGTCA-3# (sense) and
5#-GCTACGGACCTAAGTAGCTATTC-3# (anti-sense) and for
IFN-c were 5#-CATTGAAAGCCTAGAAAGTCTG-3# (sense)
and 5#-CTCATGAATGCATCCTTTTTCG-3# (anti-sense).
Sense and anti-sense primers were chosen on different
exons separated by large intronic sequences which enabled
unambiguous differentiation of cDNA from contaminating ge-
nomic DNA amplification products as described by Reiner
et al. (12). Forty cycles were performed in this PCR. The
thermal cycling conditions were as follows: 94C for 40 s,
60C for 20 s, 72C for 40 s, followed by a final incubation
at 72C for 10 min. The simultaneous amplification of the cy-
tokine gene in the first-strand cDNA and of a serial dilution
of competitor of known concentration allowed the determina-
tion of the level of IL-4- and IFN-c-specific transcripts. The
point of equivalence in intensity between the competitor
(upper band) and the cDNA (lower band) indicates the rela-
tive concentration of mRNA.
Subcutaneous injection of tick saliva-pulsed DCs. Purified
splenic DCs (2 3 105) were pulsed or not with 15 lg of
I. ricinus tick saliva in vitro overnight in 500 ll of complete
RPMI-1640. Controls were maintained in RPMI-1640 me-
dium. Cells were washed and re-suspended in 1 ml of PBS
(50 mM, pH 7.4), and were then injected subcutaneously at
the level of the shoulder into one flank of five BALB/c mice.
Nine days after inoculation, mice were killed, and the axillary
and brachial draining lymph nodes were removed. The
draining lymph node cell suspensions were prepared and
used in secondary stimulation in vitro with tick saliva. Results
were assessed by the quantification of T cells proliferation
and ELISA cytokine assay.
Secondary stimulation of draining lymph node T cells with
tick saliva in vitro
In vitro proliferation. Draining lymph node cells per well (106)
prepared from mice injected with tick saliva-pulsed DCs or
control DCs were stimulated with 2, 4 and 8 lg of tick saliva.
Cells were cultured in 200 ll total volume of complete RPMI-
1640 during 96 h at 37C and saturated atmosphere and 5%
CO2. Twenty-four hours before harvesting cells, 1 lCi per
well of methyl [3H]TdR was added. Methyl [3H]TdR incorpo-
ration was determined by liquid scintillation counting.
In vitro IL-4 and IFN-c production. Draining lymph node cells
per well (106) prepared from mice injected with tick saliva-
pulsed DCs or control DCs were stimulated with 4 lg of tick
saliva. Culture supernatants were collected and used for
IL-4 and IFN-c quantification using an ELISA as previously
reported (13). Dilutions of rIL-4 (12.5–400 U ml1) or rIFN-c
(4–125 U ml1) (PharMingen, Heidelberg, Germany) were
used for construction of standard curves.
Flow cytometry. To assess the modification of adhesive and
co-stimulatory molecules’ expression on naive DCs that were
either treated or not with tick saliva, or tick saliva plus IL-1b,
flow cytometry analysis was performed. Cells were cultured
during 7 days at 37C and 5% CO2. They were then har-
vested, washed and re-suspended in the staining buffer
composed of PBS, 0.05% NaN3 and 0.5% BSA. Aliquots of
105 cells/50 ll were incubated each with 1 lg of CD16/CD32
for 20 min in the dark, in order to block non-specific binding
of antibodies to the FccIII and FccII receptors, and subse-
quently incubated for 30 min with 1 lg of the following FITC-
labelled antibodies: anti-Iab, anti-CD80 (B7-1), anti-CD86
(B7-2), anti-CD40 or anti-CD54 (ICAM-1) (all from PharMingen).
The corresponding primary-labelled isotype control antibodies
were used for staining controls. Thereafter, cells were washed
twice with the staining buffer and re-suspended in 500 ll of
FACS buffer (0.15 M NaCl, 1 mM NaH2PO4 H2O, 10 mM
Na2HPO4 2H2O and 3 mM NaN3). Cells were FACS analysed
on a FACScan (Becton Dickinson, Heidelberg, Germany) us-
ing the corresponding CellQuest software.
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Results
Expression of IL-4 and IFN-c cytokines’ mRNA during
primary stimulation of CD4+T cells
Naive splenic CD4+T cells (5 3 105), primarily stimulated in
vitro in growth medium in the presence of tick saliva-pulsed
DCs or only DCs as control, were collected for mRNA analy-
sis. IL-4 and IFN-c mRNA levels were determined by com-
petitive quantitative reverse transcription–PCR at day 7 of
the culture. Cytokine mRNA concentrations of the Th1 and
Th2 phenotype were compared (Fig. 1a). Splenic CD4
+T
cells primed in vitro with saliva-pulsed DCs expressed more
IL-4 mRNA (100 pg ll1) than IFN-c mRNA (20 pg ll1).
These results indicate that tick saliva-pulsed DCs induce
the differentiation of naive CD4+T cells into a Th2 phenotype
in vitro. When stimulated with non-pulsed control DCs,
splenic CD4+T cells expressed high levels of both IL-4 and
IFN-c mRNA. IL-4 mRNA was not detectable in CD4+T cells
primarily stimulated in vitro with tick saliva-pulsed DCs in
the presence of neutralizing anti-IL-4 mAbs (Fig. 1b). Lower
amount of IFN-c mRNA (5 pg ll1) was expressed by CD4+T
cells when cultures were treated with anti-IL-4 compared
with that of untreated culture (20 pg ll1). In vitro Th2 differ-
entiation of CD4+T cells did not occur after treatment with
neutralizing anti-IL-4. Nevertheless, this treatment did also
not lead to the development of Th1 cells.
Effect of IL-1b addition during the primary culture on
stimulated CD4+T cells proliferation in vitro
CD4+T cells primed in vitro with tick saliva-pulsed DCs or
control DCs in the presence or absence of IL-1b were re-
stimulated in vitro with tick saliva-pulsed DCs or control DCs
(Fig. 2). Results showed that CD4+T cells primed in pres-
ence of IL-1b displayed a higher proliferation when second-
ary stimulated with tick saliva-pulsed DCs than with control
DCs. CD4+T cells primed in the absence of IL-1b did not dis-
play a significant proliferation when secondary stimulated
either with tick saliva-pulsed DCs or with control DCs. Like-
wise, no significant proliferation was recorded when CD4+T
cells were primed with DCs alone even if IL-1b was present.
This showed that in primary culture the presence of saliva
was indispensable while IL-1b was necessary, but not suffi-
cient, for CD4+T cells proliferation.
Effect of IL-1b addition during secondary in vitro stimulation
on CD4+T cells proliferation
CD4+T cells were primed in vitro with tick saliva-pulsed DCs
in the presence or absence of IL-1b. CD4+T cells primed in
absence of IL-1b did not proliferate when co-cultured in vitro
with tick saliva-pulsed DCs in the presence or absence of IL-
1b. On the other hand, CD4+T cells primed in the presence
of IL-1b displayed a similar high degree of proliferation no
matter whether IL-1b was added or not to the culture me-
dium in the secondary stimulation in vitro (Fig. 3). Results
show that only CD4+T cells primed in vitro in the presence
of IL-1b proliferate following the secondary stimulation. This
finding indicates that the presence of IL-1b was required
early during primary stimulation but not during secondary
stimulation to induce proliferation of Th2 cells primed in vitro.
Co-stimulatory molecules’ expression by activated DCs
The expression of selected major co-stimulatory molecules
involved in the accessory activity of DCs was analysed. As
shown in Fig. 4, IL-1b treatment of ticks saliva-pulsed DCs
up-regulated surface expression of B7-1 (CD80) and to a
lesser extent B7-2 (CD86), but markedly CD40 co-stimula-
tory molecules. In the absence of IL-1b, tick saliva treatment
of naive DCs increased drastically the expression of B7-2
(CD86) and to lesser extent CD40 molecules, while B7-1 ex-
pression remained very low. The class II molecules (Ia) were
increased by DCs pulsed with tick saliva in the presence or
absence of IL-1b. The surface expression levels of Ia mole-
cules as well as co-stimulatory molecules remained very
low in untreated DCs, while the expression of the adhesion
molecule ICAM-1 (CD54) was significantly up-regulated
in comparison with the treated DCs. The up-regulation of
the co-stimulatory molecules, especially B7 molecules
Fig. 1. Reverse transcription–PCR-based determination of the rela-
tive levels of IL-4 and IFN-c mRNA, expressed by CD4+T cells primed
in vitro with tick saliva-pulsed DCs or control DCs, performed either in
the absence of anti-IL-4 (a) or in the presence of anti-IL-4 (b). The
results presented are from a single experiment of three independent
experiments showing virtually identical results. Ethidium bromide
agarose-stained gels of representative PCRs using IL-4- and IFN-c-
specific primers in the presence of indicated serial dilutions of
a competitor, for IL-4 and IFN-c mRNA. Two microlitres of 2-fold
diluted cDNA were used as template. The point of equivalence in
intensity between the competitor fragment (CF) and the cDNA
indicates the relative concentration of IL-4 and IFN-c mRNA (see
arrows) in CD4+T cells primed in vitro.
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and CD40, which is a prerequisite for full T cell activation,
appeared to take place when tick saliva-pulsed DCs were
treated in culture with IL-1b.
Activation of draining lymph node T cells primed in vivo with
I. ricinus saliva-pulsed DCs
Nine days following subcutaneous injection of tick saliva-
pulsed DCs into BALB/c mice, an increase of the size of axil-
lary and brachial lymph nodes draining the site of inocula-
tion was observed in situ. In contrast, the size of lymph
nodes of the non-inoculated site has not changed (data not
shown). Control mice received only DCs.
The activation of draining lymph node T cells primed in vivo
with tick saliva-pulsed DCs or control DCs was assessed by
the determination of the level of proliferation and cytokines
(IL-4 versus IFN-c) production. In secondary stimulation in
vitro, primed draining lymph node T cells with the tick sa-
liva-pulsed DCs exhibited, following stimulation with different
protein–saliva concentration 2, 4 and 8 lg ml1, a high level
of proliferation [>90 3 103 counts per minute (c.p.m.)]. The
maximal of proliferation (145.213 3 103 c.p.m. 6 8.259 SD)
was reached when primed T cells were stimulated with
4 lg ml1 of protein–saliva. As a control, the proliferation of
draining lymph node T cells primed in vivo with only DCs
remained relatively very low (<25 3 103 c.p.m.) at different
point of protein–saliva concentration.
Four micrograms per millilitre was the point of protein–
saliva concentration that induce the higher level of prolif-
eration used in the same cultures in view to collect the
supernatant for the determination by ELISA of the amount of
produced cytokines as IL-4 versus IFN-c. Results re-
vealed that draining lymph node T cells from mice injected
with tick saliva-pulsed DCs produced higher level of IL-4
(16.2 U ml1 6 1.9 SD) than IFN-c (0.3 U ml1 6 0.2 SD),
while in the control, draining lymph node T cells from mice
injected only with DCs secreted low amounts of both IL-4
(2 U ml1 6 0.5 SD) and IFN-c (0.45 U ml1 6 0.15 SD).
The higher dose of IL-4 than IFN-c produced by lymph
node cells in secondary stimulation indicated that primarily
tick saliva-pulsed DCs that reach the T cell area of the lymph
node activate salivary antigen-specific T cells to differentiate
into Th2 cells; moreover, it appears that these cells react
very fast to the low doses of saliva to proliferate and to
produce IL-4.
Fig. 2. Effect of the addition of IL-1b during stimulation on the proliferation of primed splenic CD4+Tcells following secondary stimulation with tick
saliva-pulsed DCs or control DCs. Splenic CD4+T cells cultured either with tick saliva-pulsed DCs in the presence or absence of IL-1b or control
DCs plus IL-1b were secondarily stimulated with tick saliva-pulsed DCs or control DCs. Twenty-four hours before harvesting cells, 1 lCi per well
of methyl [3H]TdR is added, and incorporation of radioactivity was determined by liquid scintillation counting. Each value represents the mean of
triplicate wells 6 SD from a single experiment representative of three separate experiments. ps+IL-1b CD4
+T cells = CD4+T cells primed in
presence of saliva and IL-1b. ps CD4
+T cells = CD4+T cells primed in presence of saliva and absence of IL-1b. pIL-1b CD4
+T cells = CD4+T cells
primed in absence of saliva and presence of IL-1b.
Fig. 3. Comparison of the effect of the addition of IL-1b on splenic CD4+T cells proliferation during primary and secondary in vitro stimulation.
Splenic CD4+T cells primed in vitro with ticks saliva-pulsed DCs in the presence or absence of IL-1b were re-stimulated under the same
conditions. Twenty-four hours before harvesting cells, 1 lCi per well of methyl [3H]TdR is added. Incorporation of radioactivity was determined by




Pathogen-free Ixodidae vectors such as the prostriates,
Ixodes scapularis and Ixodes pacificus, bias the immune
response of C3H mice toward Th2 (14). The metastriates,
Dermacentor andersoni and Rhipicephalus sanguineus, are
also able to induce Th2 immune response into BALB/c mice
(15) and C3H/HeJ mice (16), respectively. In our system,
I. ricinus infestation of mice with different backgrounds,
BALB/c (H-2d), DBA (H-2d), C57BL/6 (H-2b), CBA (H-2k),
C3H (H-2k), SJL (H-2s) and FVB (H-2q), produce always this
type 2 immune response (6). Ixodes scapularis infected with
B. burgdorferi induce a Th2 immune response in Lyme dis-
ease susceptible C3H/HeJ mice (17). Exogenous delivery of
the Th1 cytokines, IFN-c and IL-2, given at the time of tick
feeding on mice, suppresses spirochetes transmission by
I. scapularis (18). Christe et al. (4) show that BALB/c devel-
ops a mixed Th1/Th2 response after syringe inoculation of
B. burgdorferi and a Th2 immune response against the path-
ogen after tick inoculation. These results evidenced the cru-
cial role of tick saliva in the Th2 polarization of the mice
immune response. The importance of tick saliva is revealed
in their ability to modulate host immune response. Indeed,
R. sanguineus tick saliva increases IL-10 and diminishes
IFN-c production by Trypanosoma cruzi-stimulated cells
(11). Later, it showed to be able to reduce IL-12 and in-
crease transforming growth factor-b production by murine
cells cultured with trypomastigote forms of T. cruzi (16).
These results support the view that R. sanguineus ticks may
modulate the host’s cytokine network and enhanced espe-
cially the production of type 2 cytokines. Moreover, IL-10
produced by tick-infested mice can interfere with functional
maturation of DCs, and can selectively inhibit their capacity
to induce the development of IFN-c-producing T cells in vivo,
favouring Th2 differentiation.
DCs are specialized APCs required for the priming and ac-
tivation of CD4+T cells (9). They are the most potent APCs in
priming L. major-specific T cells, followed closely by B cells
and finally by macrophages (19). In our work, the ability of
I. ricinus saliva to direct the differentiation of IL-4-secreting
naive CD4+T cells toward a Th2 type of immune response
was demonstrated using an in vitro priming system. Tick sa-
liva-sensitized Th2 cells were obtained by co-culturing naive
CD4+T cells with tick saliva-pulsed DCs during 7 days. This
period of time has also been considered to be optimal in
other systems (19, 20). Primed CD4+T cells expressed higher
levels of IL-4 than IFN-c mRNA, and these levels remained
lower than those observed in the control. This could be due
to the relatively reduced number of naive T cell populations,
responding specifically to saliva-pulsed DCs and differentiat-
ing into specific Th2 cells. Suppressive effects of some
saliva molecules on T cell activation are not excluded. In fact,
I. ricinus saliva contains immunosuppressive as well as im-
munogenic molecules (21). However, the presence of sup-
pressive molecules does not interfere with the establishment
of Th2 immune response in vivo. The high levels of IL-4 and
IFN-c mRNA measured in the control cultures can be
Fig. 4. Analysis of class II (Ia), B7-1 (CD80), B7-2 (CD86), CD40 and
ICAM-1 (CD54) surface expression in DCs. The grey, the dotted and
the black lines show the level of expression of different co-stimulators
on (a) untreated DCs, (b) DCs pulsed with ticks saliva and (c) DCs
pulsed with ticks saliva plus IL-1b, respectively. This experiment was
repeated three times with virtually identical results.
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explained by the stimulation of CD4+T cell clones that have
an unrestricted profile producing IL-4 and IFN-c simulta-
neously (22). Moreover, CD4 memory T cells present in the
culture can simultaneously express IL-4 and IFN-c (23).
To comparatively assess these results obtained in vitro
with the in vivo situation, DCs were pulsed overnight with
I. ricinus saliva and were injected subcutaneously into BALB/
c mice. We found that this also induced the development of
an anti-tick Th2 immune response. The swelling of axillary
and brachial draining lymph nodes indicates that saliva-
pulsed DCs migrate from the site of inoculation to draining
lymph nodes and activate responding cells triggering the
enlargement of the secondary lymphoid organs. From the
peripheral tissue, antigen-bearing DCs reach via lymph con-
ducts the T area of lymph nodes (24). In our study, salivary
antigens-bearing DCs prime T cells in the lymph nodes that
differentiate into Th2 type of cells and proliferate ensuring
the increase of lymph node size. In this context, the activa-
tion of B cells is excluded since these cells reside in the fol-
licular area where they respond to intact free antigens that
exit the lymph or the blood and enter the lymph node. How-
ever, it was demonstrated recently an extrafollicular activa-
tion of lymph node B cells by especially particulate material
as bacterial or viral antigen-bearing DCs (25). Taking into
account this finding, an extrafollicular activation of lymph
node B cells is excluding since in our work pathogen-free
ticks reared in our laboratory were used to prepare tick sa-
liva that did not contain any pathogen. Here evidence is
available to indicate that T cells and especially Th2 cells
were activated by saliva-pulsed DCs in vivo into the lymph
nodes. In agreement with our results, it was found that
in vitro purified I. ricinus salivary gland protein with a molecu-
lar weight of 65 kDa (IrSG65) stimulated the proliferative
activity of axillary and brachial lymph node cells prepared
from mice infested with nymphal ticks. Depletion of CD4+T
cells drastically reduced the ability of lymph node cells from
infested mice to proliferate after (IrSG65) stimulation in vitro
(26). Thus, the secondary stimulation of lymph node cell
in vitro with different dose of saliva triggered the activation
of T cells that proliferate and produce IL-4 cytokine. Our
results confirmed the importance of tick saliva molecules in
the polarization phenomenon, and on the other hand, dem-
onstrate the usefulness of the in vitro priming model to as-
sess different parameters of this immune response. Similar
observations showing good correlation between in vitro and
in vivo assays were made in other infection models. For in-
stance, in the presence of phosphorylcholine-containing gly-
coprotein secreted by the nematode Acanthocheilonema
viteae, DCs induce a Th2 response while DCs maturing in
vitro in the presence of LPS promote a Th1 response (27).
IL-4 represents a reliable marker for differentiation of Th2
type of cells and down-regulation of IFN-c production (28).
The addition of exogenous IL-4 to culture of naive CD4+T
cells in the presence of mitogen (anti-CD3) (29) or allo-
antigen (30) directs the development of Th2 effector cells,
which on re-stimulation produce high levels of IL-4, IL-5 and
IL-10 as well as IL-13 and granulocyte macrophage colony-
stimulating factor. In our work, we showed that DCs pulsed
overnight with tick saliva were able to trigger the in vitro dif-
ferentiation of naive CD4+T cells into Th2 cells expressing
higher level of IL-4 than IFN-c mRNA, without the addition of
IL-4. Therefore, anti-IL-4 mAb applied in the culture inhibited
the development of IL-4-secreting Th2 cells while the expres-
sion of IFN-c by CD4+T cells remained low.
DCs-derived factors determine Th1 or Th2 immune re-
sponse. IL-12-secreting DCs1 have been shown to be re-
quired for differentiation of IFN-c-secreting Th1 cells in vitro
(31). The low expression of IFN-c mRNA following anti-IL-4
treatment in our culture system can be explained by the lack
of IL-12 secretion due to an unknown tick saliva factor, or po-
tentially by the secretion of IL-10 by DCs2, which could de-
crease the number of DCs1. Our experiments suggest that
IL-4-dependent signalling pathway is indispensable to bias
the cytokine secretion pattern toward the Th2 phenotype. In
contrast, the neutralization of any endogenous IL-4 with anti-
bodies during primary culture of T cells from TCR transgenic
mice specific for ovalbumin (OVA) and various types of APCs
pulsed with OVA results in the appearance of T cells that pro-
duce IFN-c and IL-2 upon stimulation (32). In our in vitro
priming system, the endogenous IL-4 may be secreted by
minor populations of splenic CD4+T cells such as memory
Th2 cells or naive ab CD4
+T cells. NK 1.1 CD4+T cells ex-
press a high level of IL-4 transcripts 90 min after intravenous
injection of L. major (33). In the natural infestation, IL-4 that
sets the polarization toward Th2 might be produced early by
some cells of the skin such as mast cells, keratinocytes or in-
filtrating basophiles. Previously, in our group, Mbow et al. (34)
showed by histological examination of skin biopsies that early
during the first hours of the primary infestation, mast cells
and degranulated mast cells did not vary in number. The
number of infiltration eosinophils remained very low and the
basophiles were rare or absent. However, it not exclude that
mast cells and keratinocytes stimulated by tick saliva secrete
the relatively little amount of IL-4 during the primary infesta-
tion. A higher amount of IL-4 registered in the skin during the
secondary infestation may be assigned to infiltrating baso-
philes (34). Nevertheless, a member of our group attempted
to segregate the different populations of cells from epidermis
of ear’s skin of mice primary infested by larva of I. ricinus
and checked their ability to secrete IL-4. In this experiment,
Tcd cells were found to be the mean type of cells secreting
IL-4. The pick of IL-4 production was reached at 18 h after in-
festation while the production of this cytokine by the other
T cells (Tab, CD4+T and CD8+T cells) and CD3 cells (kerati-
nocytes and granulocytes) remained very low (L. Yvan, per-
sonal communication).
Tick saliva-specific Th2 cells differentiated in vitro did
not display any proliferation either during primary stimulation
or during a secondary in vitro stimulation with tick saliva-
pulsed DCs. However, they proliferated strongly when IL-
1b was added as soluble co-stimulator in the in vitro priming
culture (Fig. 2). In accordance with our finding, Chang et al.
(35) showed that an optimal proliferation of Th2 clones in
response to IL-4 requires the addition of IL-1. Moreover,
secreted IL-1b mostly acts as a co-stimulator for the prolifer-
ation of Th2 lymphocytes (36, 37). In contrast, Th1 clones se-
crete IL-2 and proliferate without any requirement for IL-1b.
In our experiment, exogenous IL-1b was probably needed
because IL-4 secreted by Th2 cells inhibited the transcrip-
tion and secretion of IL-1b (38). In TCR transgenic T cell
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systems, neither IL-1b receptor antagonist nor antibodies to
IL-1b diminish priming for IL-4 production mediated by anti-
gen, APCs and IL-4 (39, 40). IL-1b is only required for the
proliferation of some Th2 clones in response to IL-4 but not
for the differentiation of murine CD4+T cells into Th2 clones.
In our study, it appears that proliferative responses and lym-
phokine production by Th2 cells exhibit distinct signalling
requirements. Moreover, we show that IL-1b is not required
in secondary stimulation of differentiated Th2 cells either
when CD4+T cells are primed in presence of IL-1b or in its
absence (Fig. 3). This suggests that proliferation of differen-
tiated Th2 cells require an early IL-1b-dependent signalling
pathway only during primary cell culture.
To provide further explanation to the activation of naive
CD4+T cells, we compared the expression of the major ac-
cessory molecules, such as CD40, CD80 (B7-1) and CD86
(B7-2), by FACS analysis of tick saliva-treated DCs, DCs
treated with saliva plus IL-1b, and control DCs, and
explained their role in the stimulation of CD4+T cells at day
7 of in vitro culture. Tick saliva plus IL-1b-treated DCs
exhibited mainly an increased CD40, and to a lesser extent
also B7 receptor expression. CD40 had been shown to up-
regulate the B7 co-stimulatory molecule, which stimulated
T cells via the CD28 ligand and drove the cell to enter into
the cell cycle and become fully active (41, 42). The high
level of CD40 explains also the maintenance of the high ex-
pression of the class II molecules registered in our results. It
had been reported that CD40 increased also the antigen-
presenting functions of monocytes/DCs by maintaining high
levels of MHC class II antigens and up-regulation of CD58
(leukocyte function-associated antigen-3) expression (43).
Treatment of DCs only with tick saliva induced up-regulation
of class II (Ia), CD40 and, markedly, B7-2 molecules’ expres-
sion. The strength of these co-stimulators’ expression
appeared not sufficient to drive the proliferation of primary-
stimulated CD4+T cells, but was strong enough to trigger
their differentiation into Th2 cells. The co-stimulation via B7-2
could promote the production of IL-4 by primed CD4+T cells;
however, this needs to be experimentally clarified. Many
studies showed the critical role of B7-2 in the preferential in-
duction of a Th2 immune response (44, 45). In the case of
the L. major infection model, where a dichotomy in the im-
mune response (Th1 or Th2) has been described to be de-
pendent of the strain of the infected mice (C57BL/6 versus
BALB/c), this hypothesis was supported by the finding that
treatment of BALB/c mice with neutralizing anti-B7-2 mAb
markedly reduce the levels of IL-4 produced in the lymph
nodes draining leishmanial lesions (46). However, in different
experimental models controversial results have been
obtained concerning the implication of CD80 and CD86 as
differential determinants of Th1- versus Th2-type cytokine
profiles (47, 48). While DCs untreated with tick saliva in-
crease slightly the class II (Ia) molecules but significantly
the adhesion molecule ICAM-1 (CD54), these cells are not
able to activate CD4+T cells in primary culture. ICAM-1
appeared thus to be inadequate for triggering T cell activa-
tion. Indeed, the selective contact of T cells with ICAM-1
plus MHC–peptides during priming can lead to a prominent
hypo-responsive status (49). Ixodes ricinus saliva appears
to be able to reduce DC expression of ICAM-1 (Fig. 4).
According to our findings, salivary gland extracts of D.
andersoni significantly down-regulated the expression of
ICAM-1 by endothelial cells, which may alter leukocyte mi-
gration to the bite site (50). It has also been demonstrated
that the ICAM-1–LFA-1 signalling pathway needs to be cou-
pled to the B7–CD28 signalling pathway for the activation of
lymphocytes (51).
In conclusion, the in vitro priming system employed in this
study is restricted to major elements implicated in the anti-
tick immune response such as naive CD4+T cells, whole DC
populations, and tick saliva. However, the results obtained
here are comparable to the situation in vivo with several
strains of mice (6), including BALB/c. Thus, the in vitro
model provides the possibility to delimit further the immuno-
genic saliva molecules that pulse DC subsets to induce Th2
immune response. The neutralization of these saliva putative
molecules may interfere with the establishment of Th2 im-
mune response, and subsequently with tick-borne patho-
gens’ transmission.
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